Efficacy and Safety of Programmed Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Checkpoint Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer: a Systematic Review and Meta-analysis

The aim of this systematic review with meta-analysis was to evaluate the efficacy and safety of programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) checkpoint inhibitors in patients with metastatic castration-resistant prostate cancer (mCRPC).

Source: Clinical Oncology - November 15, 2023 Category: Radiology Authors: Xuwei Hong, Yuanfeng Zhang, Zepai Chi, Qingchun Xu, Weiqiang Lin, Yueying Huang, Yonghai Zhang, Tianxin Lin Tags: Original Article Source Type: research